Alternative dantrolene product available

Pfizer Australia Pty Ltd has advised that the Australian registered medicine, DANTRIUM® powder for injection 20 mg (for intravenous injection) AUST R 14435 is unavailable due to an unexpected third party manufacturing issue.

Supply of DANTRIUM® powder for injection 20 mg is expected to resume late December 2017.
Pfizer Australia has been able to arrange supply of an alternative product, RYANODEX® (dantrolene sodium) for injectable suspension (250mg) on a temporary basis.

This product is NOT registered in Australia and supply is authorised under an exemption granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until late May 2017.

For more infoirnmation on RYANODEX® see here.
Copyright © Australian and New Zealand College of Anaesthetists.